Clinical Trials Directory

Trials / Sponsors / TILT Biotherapeutics Ltd.

TILT Biotherapeutics Ltd.

Industry · 6 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
Active Not RecruitingTNFα and IL-2 Coding Oncolytic Adenovirus TILT-123 With Lymphocyte-depleting Chemotherapy and TILs in the Trea
Metastatic Melanoma
Phase 12025-06-25
Active Not RecruitingOncolytic Adenovirus TILT-123 With Pembrolizumab as Treatment for Refractory Non-Small Cell Lung Cancer
Lung Cancer
Phase 12024-07-23
Active Not RecruitingOncolytic Adenovirus TILT-123 and Avelumab for Treatment of Solid Tumors Refractory to or Progressing After An
Melanoma, Head and Neck Squamous Cell Carcinoma
Phase 12023-03-08
RecruitingOncolytic Adenovirus Coding for TNFa and IL2 (TILT-123) With Pembrolizumab or Pembrolizumab (Phase 1a) and Peg
Platinum-refractory Ovarian Carcinoma, Platinum-resistant Ovarian Cancer, Platinum-Resistant Fallopian Tube Carcinoma
Phase 1 / Phase 22022-05-17
CompletedTNFα and IL-2 Coding Oncolytic Adenovirus TILT-123 Monotherapy
Solid Tumor
Phase 12021-01-11
CompletedTNFalpha and Interleukin 2 Coding Oncolytic Adenovirus TILT-123 During TIL Treatment of Advanced Melanoma
Metastatic Melanoma
Phase 12020-02-26